TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma

J Invest Dermatol. 2023 Feb;143(2):344-347.e3. doi: 10.1016/j.jid.2022.08.046. Epub 2022 Sep 8.
No abstract available

MeSH terms

  • Dermatitis, Exfoliative* / diagnosis
  • Dermatitis, Exfoliative* / genetics
  • Gene Expression
  • Humans
  • Membrane Proteins* / genetics
  • Mycosis Fungoides* / diagnosis
  • Mycosis Fungoides* / genetics
  • Sezary Syndrome* / diagnosis
  • Sezary Syndrome* / genetics
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / genetics

Substances

  • Membrane Proteins